About Pairwise
Pairwise is a Healthcare company based in Durham (United States) founded in 2017 by Tom Adams and Haven Baker. New crop varieties are developed using gene-editing for agrigenomics. It operates in the Healthcare and Agriculture sectors. Pairwise has raised $155 million across 3 funding rounds from investors including Monsanto, Corteva Agriscience and Temasek. Its chief executive, as recorded, is Tom Adams. Its website pairwise.com draws about 10 thousand monthly visits. Pairwise offers products and services including Fulcrumâ„¢ Platform, Seedless Blackberries, and Pitless Cherries. Its focus areas include Life Sciences, Genomics, Applied Genomics and Agrigenomics. Its competitors include Benson Hill, Cibus and Inari; 3 of its 3 listed competitors have raised funding.
Company details
Pairwise was founded in 2017 and is based in Durham, United States. Operations focus on agrigenomics within the biotechnology sector. New crop varieties are created by rearranging the genetic code of existing plant species through proprietary gene-editing tools. Traits that support higher yields and efficient resource use are incorporated into these varieties. Leadership includes co-founders Tom Adams as CEO and Haven Baker.
- Headquarters Durham, United States
- Founders Tom Adams, Haven Baker
- SectorsHealthcareAgriculture
- Phone•••• ••••
- Website pairwise.com
- Social LinkedIn X
- Total Equity Funding$155M (USD)
in 3 rounds
- Latest Funding Round$40M (USD), Series C
Sep 2024
- InvestorsMonsanto
& 5 more
Products & Services of Pairwise
Pairwise offers a comprehensive portfolio of products and services, including Fulcrum™ Platform, Seedless Blackberries, and Pitless Cherries.
Platform for editing plant genetics to create sustainable crops.
Gene-edited fruit for enhanced consumer convenience and yield.
Edited cherries to improve ease of consumption and production.
Funding Insights of Pairwise
Pairwise has successfully raised a total of $155M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $40 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $155M
- Total Rounds 3
- Last Round Series C — $40M
- First Round $25M
(Mar 2018)
- Investors Count 6
All 3 funding rounds of Pairwise with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $40M | Series C | – | Deerfield | |
| Feb 2021 | $90M | Series B | – | Deerfield, Aliment Capital | |
| Mar 2018 | $25M | Series A | – | Deerfield, Monsanto | – |
6 investors in total: 6 institutional.
Investors in Pairwise
Pairwise has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Monsanto, Corteva Agriscience and Temasek.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare ecosystem is supported through investment and innovation by Deerfield. | deerfield.com | New York, United States | ||
Aliment Capital is focused on sustainable food system investments. | alimentcap.com | Los Angeles, United States | ||
Venture capital firm investing in life sciences sector | leaps.bayer.com | Leverkusen, Germany | ||
An investment platform is provided for diverse sectors and geographies. | 1974 | temasek.com.sg | Singapore, Singapore | |
Manufacturer and supplier of agricultural farm inputs | 2017 | corteva.com | Wilmington, United States | |
Genetically modified seeds and biotechnology traits are developed for farmers. | 1901 | monsanto.com | St. Louis, United States |
Investor details for Pairwise
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Pairwise
55 people are tracked at Pairwise (21 in leadership, 34 in team).
| Name | Role | Group |
|---|---|---|
Tom Adams | Co-Founder & CEO | Leadership |
Haven Baker | Co-Founder | Leadership |
Wendy Webb Williams | General Counsel & VP, Operations | Leadership |
Aaron Hummel | VP, Research & Development | Leadership |
Nat Graham | Associate Director, Molecular Biology | Leadership |
Jackie Jackson | Director Of Finance And Treasurer | Leadership |
Nate Lunt | Senior Director Of Business Developmetn | Leadership |
Drew Fister | Associate Director - Berries Program | Leadership |
Pradeep Reddy Marri | Associate Director, Tech. Dev. And CE | Leadership |
Matthew Edwards | Senior Director, IP Strategy | Leadership |
Ian Miller | Chief Operating Officer | Leadership |
Dan Jenkins | Vice President Regulatory And Government Affairs | Leadership |
Lucy Wert | Director, HR | Leadership |
Tom Spaulding | VP, Commercial | Leadership |
Joseph Watts | Associate Director, Biochemistry | Leadership |
Dan Kurdys | Executive Vice President Business Development | Leadership |
Anabel Rivas | Director, Crop Technical Development | Leadership |
Jorge Venegas | Latin America Berry Operations Director | Leadership |
Ryan Bartlett | Chief Technology Officer | Leadership |
Shai Lawit | R&d Senior Director And Head Of Trait Strategy & Testing | Leadership |
35 more people are available in the full profile.
Complete people profiles for Pairwise
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Pairwise
3 dated milestones of Pairwise across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Pairwise is founded.
- Funding First funding round of $25.0M.
- Funding Latest funding round, Series C, of $40.0M.
Competitors of Pairwise
Pairwise has 3 listed competitors in our database, 3 of them funded. They include Benson Hill, Cibus and Inari.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bensonhill.com | 2012 | St. Louis, United States | $406.99M | 151 | Provider of plant-based food ingredients | |
| cibus.com | 2001 | San Diego, United States | $34.47M | 129 | Gene editing solutions are provided for agriculture. | |
| inari.com | 2016 | Cambridge, United States | $708M | 143 | Breeding technology is provided by Inari to design seeds. |
Detailed competitors of Pairwise
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Pairwise
The website of Pairwise (pairwise.com) receives about 10.4K visits a month.
- Monthly visits10.4K
▲ 15.5% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Pairwise (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pairwise
Complete news archive for Pairwise
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pairwise
Pairwise was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Pairwise is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Tom Adams is the CEO of Pairwise, as recorded in our data. They have also founded this company.
Pairwise is a funded company, having raised a total of $155M across 3 funding rounds to date. The company's 1st funding round was a Series A of $25M, raised on Mar 2018.
Pairwise was founded in 2017 and is based in Durham, United States. Operations focus on agrigenomics within the biotechnology sector. New crop varieties are created by rearranging the genetic code of existing plant species through proprietary gene-editing tools. Traits that support higher yields and efficient resource use are incorporated into these varieties. Leadership includes co-founders Tom Adams as CEO and Haven Baker.
Pairwise's top competitors include Benson Hill, Cibus and Inari.
Pairwise offers Fulcrumâ„¢ Platform, Seedless Blackberries, and Pitless Cherries.
Pairwise has 6 investors. Key investors include Monsanto, Corteva Agriscience, Temasek, Deerfield, and Aliment Capital.